Treatment of Chronic Hepatitis C – Zepatier by Merck & Co. Inc.

Globally, between 130–150 million people globally have chronic hepatitis C infection. Approximately 700 000 people die each year from hepatitis C-related liver diseases. Antiviral medicines can cure approximately 90% of persons with hepatitis C infection, thereby reducing the risk of death from liver cancer and cirrhosis, but access to diagnosis and treatment is low. Hepatitis C… Read More Treatment of Chronic Hepatitis C – Zepatier by Merck & Co. Inc.